Syndax Pharmaceuticals | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (42)

View All

Latest Posts

About This Stock More About This Stock
3 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Monday, October 1, 2018 8:21 PM EDT
Catalyst Trading in biotech stocks can be very profitable. Often times, many catalyst events are over looked by the market, especially when it comes to small cap biotech.
In this article: AFMD, BLRX, SNDX Also: BMY, FPRX
Read
Syndax IPO Reboot May Help The Fight Against Cancer Tumors
Article By: IPO Candy
Tuesday, March 1, 2016 1:19 PM EDT
Syndax Pharmaceuticals Inc. is set to price its Nasdaq IPO this Wed. night, 3.2.2016. The company will offer 4.4 million shares at an expected price range of $14 to $16.
In this article: SNDX
Read
Syndax Pharmaceuticals IPO: Supported By A Strong Syndicate
Article By: Don Dion
Tuesday, March 1, 2016 12:11 PM EDT
Based in Waltham, Massachusetts, Syndax Pharmaceuticals Inc. is a late-stage biopharmaceutical company that is developing therapeutics for cancer. SNDX set to price its Nasdaq IPO this Wed. night, 3.2.2016;
In this article: SNDX
Read
All Posts

Latest Tweets for $SNDX

No tweets yet!

PARTNER HEADLINES